FTC sues main pharmacy benefit managers more than insulin costs The company introduced action in opposition to Caremark, Convey Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating techniques “artificially inflated” the listing price of everyday living-saving insulin prescription drugs. Elevance lowers advice on ‘unprecedented’ Medicaid challenges Executives expla... https://raymondggcaz.blogdosaga.com/30553959/the-5-second-trick-for-healthcare-news